Docket Management
Docket: 03N-0059 - Pharmaceutical Current Good Manufacturing Practices for the 21st Century: A Risk-Based Approach
Comment Number: EC -15

Accepted - Volume 1

Comment Record
Commentor Mrs. G.Sundar Sundaram Date/Time 2003-03-17 05:09:32
Organization Cipla ltd
Category Company

Comments for FDA General
1. General Comments Pl provide details of risk based approach on bulk drugs and synthetics chemicals. pl tell me the gudelines and criterion for risk based cgmp

EC -15